Parallel Advisors’s Shattuck Labs STTK Stock Holding History

Parallel Advisors’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-68	Closed	-$1K	–	3265
2021 Q4	$1K	Buy	+68	New	+$937	﹤0.01%	2966

Other funds holding STTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCG

Cloverfields Capital Group Minneapolis, Minnesota $309M AUM 20.93% 1-Year Est. Return

Parallel Advisors's STTK Position: Q1 2022 in Review

Parallel Advisors sold out of Shattuck Labs (STTK) in Q1 2022, closing a stake of 68 shares — an estimated $1K sold.

Parallel Advisors first reported a position in STTK in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 77 funds tracked by Wall St. Rank hold STTK as of Q1 2022.

Parallel Advisors reported no remaining Shattuck Labs position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 68 Shattuck Labs shares in Q1 2022, an estimated $1K.
Parallel Advisors first reported a position in Shattuck Labs in Q4 2021 and held it in 1 quarter.
Parallel Advisors's Shattuck Labs position peaked at $1K in Q4 2021.
77 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.